Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bedoyecta is a high-potency multivitamin brand primarily composed of B-complex vitamins, used for the prevention and treatment of vitamin deficiencies and associated neurological disorders. The product line includes oral capsules and an injectable formulation known as Bedoyecta Tri. The oral version typically contains a combination of thiamine (B1), riboflavin (B2), pyridoxine (B6), cyanocobalamin (B12), folic acid (B9), ascorbic acid (Vitamin C), and iron. The injectable form is specifically formulated with hydroxocobalamin, thiamine, and pyridoxine, and is frequently indicated for the management of neuritis, polyneuritis, and various neuropathies. Developed by Laboratorios Grossman (a subsidiary of Bausch Health), Bedoyecta is widely utilized in Mexico as a pharmaceutical product and is marketed in the United States as a dietary supplement to support energy metabolism and nervous system health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bedoyecta.